Replies to post #2305 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

…why would the named officers deserve an 'incentive' for something they have no control over going forward?

MNTA’s officers may not be able to make FDA approval happen, but they are surely capable of making it not happen by failing to address the FDA’s concerns. So, as a shareholder, I do want officers to have a direct economic incentive to work for Copaxone approval.